Stem-cell therapy: hope and hype
N Scolding - The Lancet, 2005 - thelancet.com
In the fifth year since human cloning to generate stem cells was legalised in the UK, what
progress has been made towards taking stem-cell therapy from laboratory to clinical …
progress has been made towards taking stem-cell therapy from laboratory to clinical …
Stem cell based therapy—where are we going?
D Ilic, J Polak - The Lancet, 2012 - thelancet.com
Cell based regenerative therapy with stem cells from bone marrow has been reported widely
and used for more than 50 years. 1 However, use of stem cells for regenerative medicine …
and used for more than 50 years. 1 However, use of stem cells for regenerative medicine …
Human embryonic stem cells: early hints on safety and efficacy
A Atala - The Lancet, 2012 - thelancet.com
In The Lancet, Steven Schwartz and colleagues1 report the first clinical experience of
patients treated with cells derived from human embryonic stem cells (hESCs). A patient with …
patients treated with cells derived from human embryonic stem cells (hESCs). A patient with …
Semantics and ethics of human embryonic stem-cell research
F Shenfield - The Lancet, 2005 - thelancet.com
The ethical debate about human embryonic stem-cell research has revisited the old embryo-
research debate, which UK law put within a framework as long ago as 1990, 1 licensing it …
research debate, which UK law put within a framework as long ago as 1990, 1 licensing it …
Clinical challenges in providing embryos for stem-cell initiatives
CLR Barratt, JC St John, M Afnan - The Lancet, 2004 - thelancet.com
Comment because they would otherwise be discarded, they obviate many of the ethical
issues about donation of embryos for research and allow for the generation of disease …
issues about donation of embryos for research and allow for the generation of disease …
[引用][C] Stem-cell therapy: what dose should we use?
T Ng - The Lancet, 2004 - thelancet.com
4 Gaspardone A, De Fabritiis, Scaffa R, et al. Stem cell mobilisation after coronary artery
bypass grafting. Ital Heart J 2004; 5 (suppl 1): 23–28. 5 Kang HJ, Kim HS, Zhang SY, et al …
bypass grafting. Ital Heart J 2004; 5 (suppl 1): 23–28. 5 Kang HJ, Kim HS, Zhang SY, et al …
Lancet Commission: Stem cells and regenerative medicine
Executive summary In this Commission, we argue that a combination of poor quality science,
unclear funding models, unrealistic hopes, and unscrupulous private clinics threatens …
unclear funding models, unrealistic hopes, and unscrupulous private clinics threatens …
Feeder-free derivation of human embryonic stem-cell lines
O Hovatta, H Skottman - The Lancet, 2005 - thelancet.com
Comment embryonic stem-cell lines in 1981. 2, 3 Unlike in the mouse, 4 leukaemia-
inhibitory factor was not able to maintain the non-differentiated growth of human embryonic …
inhibitory factor was not able to maintain the non-differentiated growth of human embryonic …
Human embryonic stem cells derived without feeder cells
I Klimanskaya, Y Chung, L Meisner, J Johnson… - The Lancet, 2005 - thelancet.com
Background Human embryonic stem cells are likely to play an important role in the future of
regenerative medicine. However, exposure of existing human embryonic stem-cell lines to …
regenerative medicine. However, exposure of existing human embryonic stem-cell lines to …
New cells from old
N Scolding - The Lancet, 2001 - thelancet.com
For personal use only. Reproduce with permission from The Lancet Publishing Group. by a
report describing the development and “overgrowth” of ectodermal and mesenchymal tissue …
report describing the development and “overgrowth” of ectodermal and mesenchymal tissue …